Join the leading experts as they go in-depth on some of the most important topics in dermatology. Hear invaluable insights on mechanism of disease, treatment options, and more for some of the most challenging dermatologic conditions.
TYK2 Inhibitors
Next-Gen TYK2 Inhibition: Redefining Oral, Systemic Treatment for Psoriasis
Featuring Jason Hawkes, MD, MS
Atopic Dermatitis
Fall Clinical Continuity Experience - Vtama - Lecture Recap Video
Featuring Peter Lio, MD
Psoriasis
Four Years of Data: Durability and Distinction with TYK2 Inhibition
Featuring Michael Cameron, MD
Eczema
LAUNCH ALERT: FDA Approves Anzupgo (Delgocitinib) Cream for Moderate-to-Severe Chronic Hand Eczema in Adults
Featuring James Del Rosso, DO
Psoriasis
Bimzelx in Focus: Versatile Care for Enhanced Dermatologic Outcomes
Featuring E. James Song, MD, FAAD
Psoriasis
Discover VTAMA: A Next-Generation Treatment for Plaque Psoriasis
Featuring Mona Shahriari, MD
Cutaneous Melanoma
Exploring the MyPath Melanoma Test for Guiding Management and Care Decisions in Patients with Ambiguous Lesions
Featuring Aaron Farberg, MD
Psoriasis
Bimekizumab for Plaque Psoriasis: Its Impact in Clinical Practice
Featuring G. Michael Lewitt, MD | Omar Noor, MD, FAAD
Psoriasis
Bimekizumab for Plaque Psoriasis: Insights into Efficacy, Safety, and Dosing
Featuring James Del Rosso, DO | Alice Gottlieb, MD, PhD
Psoriasis
Psoriasis mechanism of disease: Pathogenesis
Featuring Andrew Blauvelt, MD, MBA | Jason Hawkes, MD, MS
Psoriasis
Psoriasis mechanism of disease: Genetic, environmental, and lifestyle factors
Featuring George Han, MD, PhD | Andrew Blauvelt, MD, MBA